282
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Effect of Oral versus Vaginal Administration of Estradiol and Dydrogesterone on the Proliferative and Secretory Transformation of Endometrium in Patients with Premature Ovarian Failure and Preparing for Assisted Reproductive Technology

, , , , &
Pages 1521-1529 | Published online: 14 Apr 2021

References

  • LeQV, AbhariS, AbuzeidOM, et al. Modified natural cycle for embryo transfer using frozen-thawed blastocysts: a satisfactory option. Eur J Obstet Gynecol Reprod Biol. 2017;213:58–63. doi:10.1016/j.ejogrb.2017.04.01028437630
  • TourgemanDE, SlaterCC, StanczykFZ, PaulsonRJ. Endocrine and clinical effects of micronized estradiol administered vaginally or orally. Fertil Steril. 2001;75(1):200–202. doi:10.1016/S0015-0282(00)01640-X11163838
  • LiaoX, LiZ, DongX, ZhangH. Comparison between oral and vaginal estrogen usage in inadequate endometrial patients for frozen-thawed blastocysts transfer. Int J Clin Exp Pathol. 2014;7(10):6992–6997.25400786
  • GilmanAG. Goodman and Gilman’s the Pharmacological Basis of Therapeutics. 1990.
  • BenzigerDP, EdelsonJ. Absorption from the vagina. Drug Metab Rev. 1983;14(2):137–168. doi:10.3109/036025383089913876301793
  • TourgemanDE, GentzcheinE, StanczykFZ, PaulsonRJ. Serum and tissue hormone levels of vaginally and orally administered estradiol. Am J Obstet Gynecol. 1999;180(6):1480–1483. doi:10.1016/S0002-9378(99)70042-610368494
  • BenninkHJ, BoerrigterPJ. Use of dydrogesterone as a progestogen for oral contraception. Steroids. 2003;68(10–13):927–929. doi:10.1016/j.steroids.2003.07.00614667985
  • MitwallyMF, DiamondMP, AbuzeidM. Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization–embryo transfer. Fertil Steril. 2010;93(2):554–569. doi:10.1016/j.fertnstert.2009.02.04719362305
  • TavaniotouA, SmitzJ, BourgainC, DevroeyP. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Hum Reprod Update. 2000;6(2):139–148. doi:10.1093/humupd/6.2.13910782572
  • FatemiHM, BourgainC, DonosoP, et al. Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept. Human Reprod. 2007;22(5):1260–1263. doi:10.1093/humrep/del520
  • ZieglerDD, FanchinR. Progesterone and progestins: applications in gynecology. Steroids. 2000;65(10):671–679. doi:10.1016/S0039-128X(00)00123-911108875
  • GoldenbergRL, GrodinJM, RodbardD, RossGT. Gonadotropins in women with amenorrhea. Am J Obstet Gynecol. 1973;116(7):1003–1012. doi:10.1016/S0002-9378(16)33850-94736951
  • RebarRW, EricksonGF, YenSSC. Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril. 1982;37(1):35–41. doi:10.1016/S0015-0282(16)45973-X6800842
  • ChienLW, AuH-K, ChenPL, XiaoJ, TzengCR. Assessment of uterine receptivity by the endometrial-subendometrial blood flow distribution pattern in women undergoing in vitro fertilization-embryo transfer. Fertil Steril. 2002;78(2):245–251. doi:10.1016/S0015-0282(02)03223-512137858
  • Mohamed AmerMI, OmarOH, El Sherbiny HamedM, DahrougEG. Subendometrial blood flow changes by 3-dimensional power Doppler ultrasound after hysteroscopic lysis of severe intrauterine adhesions: preliminary study. J Minim Invasive Gynecol. 2015;22(3):495–500. doi:10.1016/j.jmig.2014.12.16525573184
  • YuX, GaoC, DaiC, YangF, DengX. Endometrial injury increases expression of hypoxia-inducible factor and angiogenesis in the endometrium of women with recurrent implantation failure. Reprod Biomed Online. 2019;38(5):761–767. doi:10.1016/j.rbmo.2018.12.02730885666
  • NikasG, DrakakisP, LoutradisD, et al. Uterine pinopodes as markers of the ‘nidation window’ in cycling women receiving exogenous oestradiol and progesterone. Human Reprod. 1995;10(5):1208–1213. doi:10.1093/oxfordjournals.humrep.a136120
  • SheshpariS, ShahnaziM, MobarakH, et al. Ovarian function and reproductive outcome after ovarian tissue transplantation: a systematic review. J Transl Med. 2019;17(1):396–410. doi:10.1186/s12967-019-02149-231783875
  • IllstonJD, WheelerTL, ParkerCR, ConnerMG, BurgioKL, GoodePS, RichterHE. Low-dose 17-β-estradiol cream for vaginal atrophy in a cohort without prolapse: serum levels and vaginal response including tissue biomarkers associated with tissue remodeling. Maturitas. 2015;81(4):475–479. doi:10.1016/j.maturitas.2015.05.01026115591
  • AlexanderNJ, BakerE, KapteinM, KarckU, MillerL, ZampaglioneE. Why consider vaginal drug administration? Fertil Steril. 2004;82(1):1–12. doi:10.1016/j.fertnstert.2004.01.02515236978
  • HammondGL. Potential functions of plasma steroid-binding proteins. Trends Endocrinol Metab. 1995;6(9–10):298–304. doi:10.1016/1043-2760(95)00162-X18406714
  • WestphalU. Steroid-Protein Interactions II. Vol. 27. Springer: Berlin, Heidelberg; 1986.
  • SudomaI, GoncharovaY, ZukinV. Optimization of cryocycles by using pinopode detection in patients with multiple implantation failure: preliminary report. Reprod Biomed Online. 2011;22(6):590–596. doi:10.1016/j.rbmo.2011.02.00421493157
  • KankiS. Cyclic changes in steroid hormone concentration and steroid hormone receptor in the human endometrium. Nihon Sanka Fujinka Gakkai Zasshi. 1982;34(12):2177–2184.7153595
  • LiuSM, ZhouYZ, WangHB, et al. Factors associated with effectiveness of treatment and reproductive outcomes in patients with thin endometrium undergoing estrogen treatment. Chin Med J. 2015;128(23):3173–3177. doi:10.4103/0366-6999.17025826612292